Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2025
Institutional positions in Terns Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 248
- +107 vs. Q3 2025
- Shares held
- 122.6M
- +34.0M (+38.3%) vs. Q3 2025
- Total value
- $4.95B
- +$4.29B (+644.0%) vs. Q3 2025
- New holders
- 124
- 72 more added
- Sold out
- 17
- 42 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 664,444 | $26.8M | 0.00% | +76,899+13.1% | Added |
| Charles Schwab Investment Management Inc | 737,160 | $29.8M | 0.00% | +153,892+26.4% | Added |
| Logos Global Management LP | 750,000 | $30.3M | 2.02% | +750,000 | New |
| Schonfeld Strategic Advisors LLC | 754,237 | $30.5M | 0.15% | −1,137,688−60.1% | Reduced |
| Deep Track Capital, LP | 769,048 | $31.1M | 0.71% | −6,725,952−89.7% | Reduced |
| Wellington Management Group LLP | 788,659 | $31.9M | 0.01% | +535,250+211.2% | Added |
| Paradigm Biocapital Advisors LP | 810,286 | $32.7M | 0.88% | +810,286 | New |
| Samlyn Capital, LLC | 814,875 | $32.9M | 0.53% | +814,875 | New |
| First Turn Management, LLC | 872,049 | $35.2M | 4.03% | +872,049 | New |
| Marshall Wace, LLP | 878,583 | $35.5M | 0.03% | +878,583 | New |
| Balyasny Asset Management LLC | 891,903 | $36.0M | 0.07% | +891,903 | New |
| Baker Bros. Advisors LP | 950,000 | $38.4M | 0.22% | +950,000 | New |
| Price T Rowe Associates Inc | 974,312 | $39.4M | 0.00% | +880,139+934.6% | Added |
| Millennium Management LLC | 987,306 | $39.9M | 0.03% | +45,722+4.9% | Added |
| FMR LLC | 1,026,863 | $41.5M | 0.00% | +966,513+1,601.5% | Added |
| Capital International Investors | 1,060,000 | $42.8M | 0.01% | +1,060,000 | New |
| Goldman Sachs Group Inc | 1,062,984 | $42.9M | 0.01% | +516,155+94.4% | Added |
| Nuveen, LLC | 1,078,157 | $43.6M | 0.01% | −395,214−26.8% | Reduced |
| D. E. Shaw & Co., Inc. | 1,154,029 | $46.6M | 0.04% | +1,154,029 | New |
| Dimensional Fund Advisors LP | 1,247,763 | $50.4M | 0.01% | −208,638−14.3% | Reduced |
| Candriam Luxembourg S.C.A. | 1,262,303 | $51.0M | 0.25% | −1,105,932−46.7% | Reduced |
| Alliancebernstein L.P. | 1,288,079 | $52.0M | 0.02% | +1,195,179+1,286.5% | Added |
| Woodline Partners LP | 1,377,283 | $55.6M | 0.22% | +1,085,228+371.6% | Added |
| Toronto Dominion Bank | 1,400,802 | $56.6M | 0.10% | +1,400,802 | New |
| Commodore Capital LP | 1,475,000 | $59.6M | 3.97% | −4,225,000−74.1% | Reduced |
| Healthcare of Ontario Pension Plan Trust Fund | 1,515,400 | $61.2M | 0.10% | +1,515,400 | New |
| Pictet Asset Management Holding SA | 1,577,116 | $63.7M | 0.06% | +472,912+42.8% | Added |
| Ikarian Capital, LLC | 1,596,378 | $64.5M | 8.35% | +1,432,176+872.2% | Added |
| Nearwater Capital Markets, Ltd | 1,704,800 | $68.9M | 1.18% | +1,704,800 | New |
| Acorn Capital Advisors, LLC | 1,746,264 | $70.5M | 23.90% | −225,000−11.4% | Reduced |
| JPMorgan Chase & Co | 1,773,026 | $71.6M | 0.00% | +1,090,318+159.7% | Added |
| State Street Corp | 1,775,922 | $71.7M | 0.00% | +170,229+10.6% | Added |
| Ameriprise Financial Inc | 1,894,381 | $76.5M | 0.02% | +1,894,381 | New |
| Geode Capital Management, LLC | 2,096,642 | $84.7M | 0.01% | +382,090+22.3% | Added |
| OrbiMed Advisors LLC | 2,153,300 | $87.0M | 1.78% | −5,409,671−71.5% | Reduced |
| Lord, Abbett & Co. LLC | 2,712,399 | $109.6M | 0.34% | +2,712,399 | New |
| Franklin Resources Inc | 2,731,312 | $110.3M | 0.03% | +1,453,849+113.8% | Added |
| Holocene Advisors, LP | 2,775,493 | $112.1M | 0.24% | +2,775,493 | New |
| Capitolis Liquid Global Markets LLC | 3,045,200 | $123.0M | 0.73% | +3,045,200 | New |
| Citadel Advisors LLC | 3,166,642 | $127.9M | 0.09% | +1,577,308+99.2% | Added |
| Janus Henderson Group PLC | 3,379,569 | $136.5M | 0.06% | +3,379,569 | New |
| Avoro Capital Advisors LLC | 4,350,000 | $175.7M | 1.73% | +4,350,000 | New |
| Vestal Point Capital, LP | 4,500,000 | $181.8M | 6.67% | +4,500,000 | New |
| Vivo Capital, LLC | 5,346,928 | $216.0M | 13.96% | −1,548,818−22.5% | Reduced |
| Vanguard Group Inc | 5,523,948 | $223.2M | 0.00% | +964,031+21.1% | Added |
| Adage Capital Partners GP, L.L.C. | 5,550,000 | $224.2M | 0.34% | +1,611,000+40.9% | Added |
| Morgan Stanley | 7,945,608 | $321.0M | 0.02% | +356,513+4.7% | Added |
| BlackRock, Inc. | 8,194,218 | $331.0M | 0.01% | +2,642,910+47.6% | Added |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −346,850−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −136,979−100.0% | Sold out |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −135,573−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −121,455−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −66,576−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −42,630−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −36,100−100.0% | Sold out |
| Stoneridge Investment Partners LLC | 0 | $0 | 0.00% | −16,867−100.0% | Sold out |
| Caxton Associates LLP | 0 | $0 | 0.00% | −15,168−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −13,196−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −12,466−100.0% | Sold out |
| Polymer Capital Management (US) LLC | 0 | $0 | 0.00% | −10,144−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −651−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −456−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −445−100.0% | Sold out |
| ZRC Wealth Management, LLC | 0 | $0 | 0.00% | −281−100.0% | Sold out |
| LGT Financial Advisors LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |